Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Poland Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20074
20084
20094
20104
20112
20126
20133
20142
20152
20161
20173
20182
20192
20201
20211
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated4
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
GlaxoSmithKline5
Novartis Pharmaceuticals4
Pfizer4
Chiesi Farmaceutici S.p.A.3
Janssen Research & Development, LLC2
MedImmune LLC2
Mereo BioPharma2
Aquinox Pharmaceuticals (Canada) Inc.1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive47
Bronchitis, Chronic6
Emphysema6
Lung Diseases4
Bronchiolitis Obliterans Syndrome3
Asthma2
Inflammation2
Respiration Disorders2
Respiratory Aspiration2
Bronchitis1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.